Stock ALC ALCON INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Alcon Inc.

Equities

ALC

CH0432492467

Medical Equipment, Supplies & Distribution

Market Closed - Swiss Exchange
Other stock markets
 11:30:41 2024-05-31 am EDT 		5-day change 1st Jan Change
80.34 CHF +0.17% Intraday chart for Alcon Inc. -2.05% +22.39%
May. 29 Switzerland's Alcon Launches Middle East Headquarters in Saudi Arabia MT
May. 22 UBS Lifts Alcon PT, Keeps Buy Recommendation MT

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 27,799 33,104 43,290 33,588 38,457 43,961 - -
Enterprise Value (EV) 1 30,797 36,050 46,201 37,288 42,057 46,962 45,689 44,271
P/E ratio -42.2 x -61.2 x 116 x 100 x 39.8 x 48.4 x 39 x 34.2 x
Yield - 0.15% 0.24% 0.33% - 0.32% 0.38% 0.42%
Capitalization / Revenue 3.7 x 4.84 x 5.22 x 3.85 x 4.07 x 4.4 x 4.12 x 3.88 x
EV / Revenue 4.1 x 5.28 x 5.57 x 4.28 x 4.45 x 4.7 x 4.28 x 3.91 x
EV / EBITDA 18.3 x 31.6 x 25.7 x 20.8 x 18.1 x 18 x 15.6 x 13.8 x
EV / FCF 83.9 x 105 x 71.6 x 64.2 x 57.6 x 36.4 x 29.1 x 23.7 x
FCF Yield 1.19% 0.95% 1.4% 1.56% 1.74% 2.75% 3.43% 4.21%
Price to Book 1.43 x 1.73 x 2.25 x 1.71 x - 2.07 x 1.98 x 1.87 x
Nbr of stocks (in thousands) 491,700 496,300 490,100 491,700 493,200 494,400 - -
Reference price 2 56.54 66.70 88.33 68.31 77.97 88.92 88.92 88.92
Announcement Date 2/25/20 2/23/21 2/15/22 2/27/23 2/27/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 7,508 6,833 8,291 8,717 9,455 9,989 10,665 11,332
EBITDA 1 1,681 1,141 1,799 1,795 2,325 2,610 2,924 3,219
EBIT 1 1,265 789 1,443 1,571 1,849 2,099 2,373 2,633
Operating Margin 16.85% 11.55% 17.4% 18.02% 19.56% 21.02% 22.25% 23.23%
Earnings before Tax (EBT) 1 -332 -635 418 463 832 1,171 1,416 1,683
Net income 1 -656 -531 376 335 974 929.5 1,200 1,411
Net margin -8.74% -7.77% 4.54% 3.84% 10.3% 9.31% 11.25% 12.45%
EPS 2 -1.340 -1.090 0.7600 0.6800 1.960 1.839 2.282 2.599
Free Cash Flow 1 367 344 645 581 730 1,291 1,568 1,866
FCF margin 4.89% 5.03% 7.78% 6.67% 7.72% 12.92% 14.71% 16.47%
FCF Conversion (EBITDA) 21.83% 30.15% 35.85% 32.37% 31.4% 49.44% 53.64% 57.97%
FCF Conversion (Net income) - - 171.54% 173.43% 74.95% 138.84% 130.68% 132.24%
Dividend per Share 2 - 0.1000 0.2159 0.2239 - 0.2859 0.3351 0.3738
Announcement Date 2/25/20 2/23/21 2/15/22 2/27/23 2/27/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2020 S1 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 S1 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 S1 2024 Q3 2024 Q4 2024 S2 2025 Q1 2025 Q2
Net sales 1 3,055 2,149 2,189 2,200 2,140 2,171 2,352 2,422 4,774 2,329 2,352 2,459 2,541 5,012 2,475 2,527 5,003 2,621 2,684
EBITDA 1 - 440 549 503 467 297 590 591 - 566 568 - 630.9 - 638.4 698.3 - 720 750
EBIT 1 -323 348 448 405 365 353 480 479 959 450 440 537 508.3 - 518 552.3 - 579.3 597
Operating Margin -10.57% 16.19% 20.47% 18.41% 17.06% 16.26% 20.41% 19.78% 20.09% 19.32% 18.71% 21.84% 20% - 20.93% 21.85% - 22.1% 22.24%
Earnings before Tax (EBT) 1 - 141 200 147 147 -31 213 213 - 238 168 335 281 - 270.7 290.7 - 369 384
Net income 1 - 139 168 148 116 -97 174 169 343 204 427 248 203.3 - 213.2 266.6 - 295 307
Net margin - 6.47% 7.67% 6.73% 5.42% -4.47% 7.4% 6.98% 7.18% 8.76% 18.15% 10.09% 8% - 8.61% 10.55% - 11.26% 11.44%
EPS 2 - 0.2800 0.3400 0.3000 0.2300 -0.2000 0.3500 0.3400 0.6900 0.4100 0.8600 0.5000 0.4118 0.9800 0.4298 0.5255 1.050 0.5900 0.6150
Dividend per Share 2 - 0.2159 - - - 0.2239 - - - - - - - - - 0.3085 - - -
Announcement Date 8/18/20 2/15/22 5/10/22 8/9/22 11/15/22 2/27/23 5/9/23 8/15/23 8/15/23 11/14/23 2/27/24 5/13/24 - - - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 2,998 2,946 2,911 3,700 3,600 3,001 1,728 310
Net Cash position 1 - - - - - - - -
Leverage (Debt/EBITDA) 1.783 x 2.582 x 1.618 x 2.061 x 1.548 x 1.15 x 0.5908 x 0.0963 x
Free Cash Flow 1 367 344 645 581 730 1,291 1,568 1,866
ROE (net income / shareholders' equity) 4.41% 2.69% 5.58% 5.69% 4.83% 7.03% 8.09% 8.52%
ROA (Net income/ Total Assets) 3.38% 1.85% 3.82% 3.87% 3.31% 4.8% 5.43% 4.33%
Assets 1 -19,403 -28,653 9,833 8,648 29,390 19,380 22,110 32,566
Book Value Per Share 2 39.50 38.50 39.30 40.00 - 43.00 44.90 47.60
Cash Flow per Share 2 1.880 1.680 2.730 2.460 2.800 4.570 5.000 5.440
Capex 1 553 479 700 636 658 737 710 731
Capex / Sales 7.37% 7.01% 8.44% 7.3% 6.96% 7.37% 6.66% 6.45%
Announcement Date 2/25/20 2/23/21 2/15/22 2/27/23 2/27/24 - - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Alcon Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
28
Last Close Price
88.92 USD
Average target price
93.37 USD
Spread / Average Target
+5.01%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Glasses, Spectacles & Contact Lenses

1st Jan change Capi.
ALCON INC. Stock Alcon Inc.
+22.39% 43.96B
ESSILORLUXOTTICA Stock EssilorLuxottica
+13.05% 101B
AUTEK CHINA INC. Stock Autek China Inc.
-20.50% 2.22B
WARBY PARKER INC. Stock Warby Parker Inc.
+25.60% 2.11B
PEGAVISION CORPORATION Stock Pegavision Corporation
+19.17% 1.13B
MINGYUE OPTICAL LENS CO.,LTD. Stock Mingyue Optical Lens Co.,Ltd.
-38.32% 716M
UNIVERSAL VISION BIOTECHNOLOGY CO., LTD. Stock Universal Vision Biotechnology Co., Ltd.
-10.65% 645M
MENICON CO., LTD. Stock Menicon Co., Ltd.
-44.53% 632M
SHANGHAI CONANT OPTICAL CO., LTD. Stock Shanghai Conant Optical Co., Ltd.
+57.22% 606M
VIZIONFOCUS INC. Stock Vizionfocus Inc.
+15.96% 463M
Glasses, Spectacles & Contact Lenses
  1. Stock Market
  2. Equities
  3. ALC Stock
  4. Financials Alcon Inc.